GenScript Peptides: difference between revisions
Diff·revision 13 → 14·07:21, 13 Nov 2025
Difference between revision 13 and revision 14 of GenScript Peptides. 9 lines changed; the page grew by 747 bytes.
| Revision 13 — 16:41, 6 Nov 2025 EndotoxinEd (talk) add the see-also to the certificate-of-analysis article 8,933 bytes +352 | Revision 14 — 07:21, 13 Nov 2025 SemaxSevi (talk) add the how-to-request-a-batch-record sentence to §Ordering and availability 9,680 bytes +747 | ||
|---|---|---|---|
| 53 | | Raw materials | Bulk powders | Certificate with purity; specification sheet on request | | 53 | | Raw materials | Bulk powders | Certificate with purity; specification sheet on request | |
| 54 | 54 | ||
| + | 55 | The custom-synthesis listings are documented differently from the catalogue lines — a certificate stating the analytical conditions under which the material was released, rather than a single purity figure against a catalogue specification. Purchaser reports describe the quotation as carrying a purity target and a timeline before the order is accepted.{{r|reports}} Whether the synthesis is performed at the Nanjing site named in the organisation's own material is not established by any source available to this wiki, and a reader should treat the attribution as a claim until it is.{{r|selfpub}} | |
| + | 56 | ||
| 55 | == References == | 57 | == References == |
| 56 | {{reflist}} | 58 | {{reflist}} |
| ⋮ | ⋮ | ||
| 62 | <ref name="ruo">Research-use-only labelling practice; see [[Research use only]] for the legal and commercial function of the phrase.</ref> | 64 | <ref name="ruo">Research-use-only labelling practice; see [[Research use only]] for the legal and commercial function of the phrase.</ref> |
| 63 | <ref name="gmp">World Health Organization, ''Good Manufacturing Practices for Pharmaceutical Products: Main Principles'', WHO Technical Report Series. The general framework against which a GMP claim is assessed.</ref> | 65 | <ref name="gmp">World Health Organization, ''Good Manufacturing Practices for Pharmaceutical Products: Main Principles'', WHO Technical Report Series. The general framework against which a GMP claim is assessed.</ref> |
| + | 66 | ||
| + | 67 | == See also == | |
| + | 68 | * [[Certificate of analysis]] | |
| + | 69 | * [[Third-party testing]] | |
| + | 70 | * [[Area percent purity]] | |
| + | 71 | * [[Peptide content]] | |
| + | 72 | * [[Research use only]] | |
| 64 | 73 | ||
| 65 | {{DEFAULTSORT:GenScript Peptides}} | 74 | {{DEFAULTSORT:GenScript Peptides}} |